Dare Bioscience (DARE) Change in Accured Expenses (2013 - 2025)

Dare Bioscience (DARE) has 13 years of Change in Accured Expenses data on file, last reported at $154554.0 in Q4 2025.

• Quarterly Change in Accured Expenses fell 88.79% year-over-year to $154554.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $572561.0 (up 233.91% YoY) and the FY2025 annual result came in at $572561.0, up 233.91% from the prior year.
• Change in Accured Expenses retreated to $154554.0 in Q4 2025, from $806077.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $6.8 million in Q4 2022 to a low of -$5.4 million in Q1 2023.
• A 5-year average of $445049.3 and a median of $130307.0 in 2024 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2021 — Change in Accured Expenses surged 3809.3% — and 2023, when it tumbled 1448.02%.
• Tracing DARE's Change in Accured Expenses over 5 years: stood at -$640500.0 in 2021, then jumped by 1155.06% to $6.8 million in 2022, then retreated by 0.85% to $6.7 million in 2023, then tumbled by 79.41% to $1.4 million in 2024, then plunged by 88.79% to $154554.0 in 2025.
• The last three Change in Accured Expenses figures came in at $154554.0 (Q4 2025), $806077.0 (Q3 2025), and $695961.0 (Q2 2025), per Business Quant data.